
Neovantage Bio-Technology Private Limited
Develops biotech buildings and land parcels in Hyderabad's biotech cluster.
Develops biotech buildings and land parcels in Hyderabad's biotech cluster.
Neovantage Bio-Technology Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2016 (Eight years and seven months 26 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.50 Cr and a paid-up capital of Rs 9.82 Cr.
The company currently has active open charges totaling ₹63.00 Cr. The company has closed loans amounting to ₹361.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shilpi Chowdhary and Chandan Mishra serve as directors at the Company.
Rangareddy, Telangana, India
+91-XXXXXXXXXX
-
U74999TG2016PTC110776
110776
Private Limited Indian Non-Government Company
09 Jul 2016
26 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shilpi Chowdhary ![]() | Director | 10-Jul-2018 | Current |
Chandan Mishra ![]() | Additional Director | 17-Oct-2024 | Current |
Neovantage Bio-Technology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 146.35% increase. The company also saw a substantial fall in profitability, with a 21.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.21%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Neovantage Bio-Technology had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Shilpi Chowdhary is a mutual person
₹63.00 Cr
₹361.60 Cr
Date | Lender | Amount | Status |
---|---|---|---|
31 Oct 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹63.00 Cr | Open |
17 Dec 2019 | Others | ₹69.60 Cr | Satisfied |
07 Sep 2018 | Others | ₹70.00 Cr | Satisfied |
27 Sep 2016 | Idbi Trusteeship Services Limited | ₹54.50 Cr | Satisfied |
27 Sep 2016 | Idbi Trusteeship Services Limited | ₹167.50 Cr | Satisfied |
Unlock and access historical data on people associated with Neovantage Bio-Technology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neovantage Bio-Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neovantage Bio-Technology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Chandan Kumar Mishra was appointed as a Additional Director was appointed as a Additional Director on 17 Oct 2024 & has been associated with this company since 4 months 18 days .
Neovantage Bio-Technology Private Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records.
Neovantage Bio-Technology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 63.00 Cr with Charge ID 100642285 was registered on 31 Oct 2022.
A charge registered on 17 Dec 2019 via Charge ID 100314853 with Others was fully satisfied on 21 Sep 2022.
A charge with Others of Rs. 69.60 Cr registered on 17 Dec 2019 with Charge ID 100314853 was modified on 19 Oct 2020.
Neovantage Bio-Technology Private Limited was incorporated on 09 Jul 2016.
The authorized share capital of Neovantage Bio-Technology Private Limited is ₹ 12.50 Cr and paid-up capital is ₹ 9.82 Cr.
Currently 2 directors are associated with Neovantage Bio-Technology Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Neovantage Bio-Technology Private Limited is Building-450 Genome Valley Turkapally (V), Shamirpet Mandal India, Hyderabad, Telangana, 500078.
The corporate identification number (CIN) of Neovantage Bio-Technology Private Limited is U74999TG2016PTC110776 and the company number is 110776 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Neovantage Bio-Technology Private Limited has risen by 146.35%.
The financial reports for the fiscal year 2022 indicates that The net worth of Neovantage Bio-Technology Private Limited has experienced an downturn of -22.21%.
As per the financial statements for fiscal Year 2022, The total open charges for Neovantage Bio-Technology Private Limited amount to ₹ 63.00 Cr.
The most recent Balance Sheet for Neovantage Bio-Technology Private Limited was filed with the ROC on 31 Mar 2024.
VG
KA